906 followers
New article: The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China https://t.co/ZZ57K3oWmJ #livercancer #oncology https://t.co/oIM8O721fk